InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Boston Scientific

BSX Clue Score87
United States Fiscal year ends December CIK 0000885725
$42.73 +1.64% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $42.73 +1.40% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue8.39Operating income0.45Net income0.35EPS, diluted0.25Fiscal year 2017Revenue9.05 +7.9%Operating income1.29Net income0.10 −70.0%EPS, diluted0.08 −68.0%Fiscal year 2018Revenue9.82 +8.6%Operating income1.51Net income1.67 +1,506.7%EPS, diluted1.19 +1,387.5%Fiscal year 2019Revenue10.74 +9.3%Operating income1.52Net income4.70 +181.3%EPS, diluted3.33 +179.8%Fiscal year 2020Revenue9.91 −7.7%Operating income−0.08Net income−0.08 −101.7%EPS, diluted−0.08 −102.4%Fiscal year 2021Revenue11.89 +19.9%Operating income1.20Net income1.04EPS, diluted0.69Fiscal year 2022Revenue12.68 +6.7%Operating income1.65Net income0.70 −32.9%EPS, diluted0.45 −34.8%Fiscal year 2023Revenue14.24 +12.3%Operating income2.34Net income1.59 +128.1%EPS, diluted1.07 +137.8%Fiscal year 2024Revenue16.75 +17.6%Operating income2.60Net income1.85 +16.0%EPS, diluted1.25 +16.8%Fiscal year 2025Revenue20.07 +19.9%Operating income3.61Net income2.89 +56.7%EPS, diluted1.94 +55.2%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 8.39 9.05 9.82 10.74 9.91 11.89 12.68 14.24 16.75 20.07
Growth +7.9% +8.6% +9.3% −7.7% +19.9% +6.7% +12.3% +17.6% +19.9%
Operating income 0.45 1.29 1.51 1.52 −0.08 1.20 1.65 2.34 2.60 3.61
Net income 0.35 0.10 1.67 4.70 −0.08 1.04 0.70 1.59 1.85 2.89
Growth −70.0% +1,506.7% +181.3% −101.7% −32.9% +128.1% +16.0% +56.7%
EPS, diluted 0.25 0.08 1.19 3.33 −0.08 0.69 0.45 1.07 1.25 1.94
Growth −68.0% +1,387.5% +179.8% −102.4% −34.8% +137.8% +16.8% +55.2%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin71.1%Operating margin5.3%Net margin4.1%Free cash flow margin9.6%Fiscal year 2017Gross margin71.3%Operating margin14.2%Net margin1.1%Free cash flow margin12.2%Fiscal year 2018Gross margin71.4%Operating margin15.3%Net margin17.0%Free cash flow margin−0.1%Fiscal year 2019Gross margin71.0%Operating margin14.1%Net margin43.8%Free cash flow margin12.8%Fiscal year 2020Gross margin65.0%Operating margin−0.8%Net margin−0.8%Free cash flow margin11.4%Fiscal year 2021Gross margin68.8%Operating margin10.1%Net margin8.8%Free cash flow margin11.1%Fiscal year 2022Gross margin68.8%Operating margin13.0%Net margin5.5%Free cash flow margin7.4%Fiscal year 2023Gross margin69.5%Operating margin16.5%Net margin11.2%Free cash flow margin12.6%Fiscal year 2024Gross margin68.6%Operating margin15.5%Net margin11.0%Free cash flow margin15.8%Fiscal year 2025Gross margin69.0%Operating margin18.0%Net margin14.4%Free cash flow margin18.2%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 71.1% 71.3% 71.4% 71.0% 65.0% 68.8% 68.8% 69.5% 68.6% 69.0%
Operating margin 5.3% 14.2% 15.3% 14.1% −0.8% 10.1% 13.0% 16.5% 15.5% 18.0%
Net margin 4.1% 1.1% 17.0% 43.8% −0.8% 8.8% 5.5% 11.2% 11.0% 14.4%
Free cash flow margin 9.6% 12.2% −0.1% 12.8% 11.4% 11.1% 7.4% 12.6% 15.8% 18.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow1.18Capital expenditure−0.38Free cash flow0.81Buybacks0.00Fiscal year 2017Operating cash flow1.43Capital expenditure−0.32Free cash flow1.11 +37.3%Fiscal year 2018Operating cash flow0.31Capital expenditure−0.32Free cash flow−0.01 −100.5%Buybacks0.00Dividends paid0.00Fiscal year 2019Operating cash flow1.84Capital expenditure−0.46Free cash flow1.38Buybacks0.00Dividends paid0.00Fiscal year 2020Operating cash flow1.51Capital expenditure−0.38Free cash flow1.13 −17.7%Buybacks−0.54Dividends paid−0.03Fiscal year 2021Operating cash flow1.87Capital expenditure−0.55Free cash flow1.32 +16.3%Buybacks0.00Dividends paid−0.06Fiscal year 2022Operating cash flow1.53Capital expenditure−0.59Free cash flow0.94 −28.7%Buybacks0.00Dividends paid−0.06Fiscal year 2023Operating cash flow2.50Capital expenditure−0.71Free cash flow1.79 +91.0%Dividends paid−0.03Fiscal year 2024Operating cash flow3.44Capital expenditure−0.79Free cash flow2.65 +47.6%Dividends paid0.00Fiscal year 2025Operating cash flow4.53Capital expenditure−0.88Free cash flow3.66 +38.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 1.18 1.43 0.31 1.84 1.51 1.87 1.53 2.50 3.44 4.53
Capital expenditure −0.38 −0.32 −0.32 −0.46 −0.38 −0.55 −0.59 −0.71 −0.79 −0.88
Free cash flow 0.81 1.11 −0.01 1.38 1.13 1.32 0.94 1.79 2.65 3.66
Growth +37.3% −100.5% −17.7% +16.3% −28.7% +91.0% +47.6% +38.3%
Buybacks 0.00 n/a 0.00 0.00 −0.54 0.00 0.00 n/a n/a n/a
Dividends paid n/a n/a 0.00 0.00 −0.03 −0.06 −0.06 −0.03 0.00 n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash0.20Total debt5.67Net cash (debt)−5.47Shareholders’ equity6.73Debt to equity0.84Fiscal year 2017Cash0.19Total debt3.82Net cash (debt)−3.63Shareholders’ equity7.01Debt to equity0.54Fiscal year 2018Cash0.15Shareholders’ equity8.73Fiscal year 2019Cash0.22Shareholders’ equity13.88Fiscal year 2020Cash1.73Shareholders’ equity15.33Fiscal year 2021Cash1.93Shareholders’ equity16.62Fiscal year 2022Cash0.93Shareholders’ equity17.57Fiscal year 2023Cash0.87Shareholders’ equity19.28Fiscal year 2024Cash0.41Shareholders’ equity21.77Fiscal year 2025Cash1.97Shareholders’ equity24.23
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.20 0.19 0.15 0.22 1.73 1.93 0.93 0.87 0.41 1.97
Total debt 5.67 3.82 n/a n/a n/a n/a n/a n/a n/a n/a
Net cash (debt) −5.47 −3.63 n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders’ equity 6.73 7.01 8.73 13.88 15.33 16.62 17.57 19.28 21.77 24.23
Debt to equity 0.84 0.54 n/a n/a n/a n/a n/a n/a n/a n/a

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
8.39 9.05 9.82 10.74 9.91 11.89 12.68 14.24 16.75 20.07
Growth +7.9% +8.6% +9.3% −7.7% +19.9% +6.7% +12.3% +17.6% +19.9%
2.42 2.59 2.81 3.12 3.47 3.71 3.96 4.35 5.26 6.22
5.96 6.46 7.01 7.62 6.45 8.18 8.73 9.90 11.49 13.85
Growth +8.3% +8.6% +8.7% −15.4% +26.8% +6.7% +13.4% +16.1% +20.6%
3.10 3.29 3.57 3.94 3.79 4.36 4.52 5.19 5.98 6.89
0.45 1.29 1.51 1.52 −0.08 1.20 1.65 2.34 2.60 3.61
Growth +187.5% +17.2% +0.8% −105.3% +37.5% +42.1% +11.1% +38.8%
0.18 0.93 1.42 0.69 −0.08 1.08 1.14 1.99 2.28 3.39
−0.17 0.83 −0.25 −4.01 0.00 0.04 0.44 0.39 0.44 0.49
0.35 0.10 1.67 4.70 −0.08 1.04 0.70 1.59 1.85 2.89
Growth −70.0% +1,506.7% +181.3% −101.7% −32.9% +128.1% +16.0% +56.7%
Per share
0.26 0.08 1.21 3.38 −0.08 0.69 0.45 1.08 1.26 1.96
0.25 0.08 1.19 3.33 −0.08 0.69 0.45 1.07 1.25 1.94
Growth −68.0% +1,387.5% +179.8% −102.4% −34.8% +137.8% +16.8% +55.2%
1,358 1,370 1,381 1,392 1,417 1,422 1,431 1,453 1,472 1,480
1,377 1,393 1,401 1,411 1,417 1,434 1,440 1,464 1,486 1,495
Growth +1.1% +0.6% +0.7% +0.4% +1.2% +0.4% +1.7% +1.5% +0.6%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 15.2% a year over five years.
  • The diluted share count rose 5.5% in five years, which is dilution.
  • Operating margin is up 18.8 points on five years ago, at 18.0%.
  • A net loss in 1 of 10 years on file.